drugset / Trial / NCT06574581

ADSCs Therapy in Patients With CTD-ILD

NCT06574581 ↗

Phase 1/2 Recruiting 16 enrolled China Medical University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Connective tissue disease (CTD), an autoimmune and inflammatory disease, usually accompanied by lung interstitial/alveolar inflammation and fibrosis (so called interstitial lung disease, ILD). The prevalence and mortality rate of CTD-ILD increase in recent several years. Although the use of corticosteroids and strong immunosuppressants can improve ILD in some patients with CTD, progressive lung fibrosis which needs lung transplantation and results in respiratory failure, even with mortality is observed. Currently, stem cell therapy is a breakthrough in the treatment of CTD-ILD, and the effective therapy with stem cells for patients with ILD have been reported.

Timeline

Start
2024-08-20
Primary completion
2027-04-30
Completion
2027-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ADSC01 Cell therapy 1e+06 cells/kg Intravenous
Subject ADSC01 Cell therapy 2e+06 cells/kg Intravenous
Subject ADSC01 Cell therapy 3e+06 cells/kg Intravenous